Focus switches from plasma to Vifor as CSL closes in on takeover
CSL shares are down 10 per cent year-to-date, but stock watchers see growth ahead for the listed biotech giant on the horizon.
Source: smh.com.au
Stay updated with breaking news from David Low. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CSL shares are down 10 per cent year-to-date, but stock watchers see growth ahead for the listed biotech giant on the horizon.
The case against Montrose man David Low, 54, was deemed not proven by the jury following the five-day trial in Dundee.
New studies reveal the complex world of bacterial epigenetics
Name: Temple Melville.
Expectant father Samuel Crawford, 28, plunged 1,000ft to his death in 'ferocious' and icy conditions on Tuesday some 3,000ft up Britain's tallest peak, Ben Nevis, in the Scottish Highlands.